The bipartisan leadership of the Senate Finance Committee released a plan to tackle drugs costs that looks to go after but not completely gut the pharmacy benefits management industry.
The 20 April framework, which Sens. Ron Wyden, D-Ore., and Mike Crapo, R-Idaho, plan to use as the basis for proposed legislation, adds further momentum to the Congressional push...